gp120/NefTat/AS02A vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for gp120/NefTat/AS02A vaccine, covering 2010-02-15 to 2010-02-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) [Phase 1]